Whether you need to generate new prospects, identify the highest-priority targets in your pipeline, or contact the right decision maker
Zymewire offers actionable sales intelligence – crafted for sales professionals selling into biotech and pharma
“See how Zymewire can change your prospecting”
Serving over 350 clients, including the world's top CROs, CMOs and other service providers across biotech & pharma
Zymewire ingests so much data that it has a pretty good idea when a new company is seen for the first time.
We use these insights to point you towards opportunities your competitors don't know about.
Funding events are a great way to identify small biotech players raising money.
Tracking early stage future plans let you get ahead of relevant R&D projects and reach out before anyone else.
Segment company lists by pipeline value, employee count, and other factors which indicate stealth status.
The end result? A prioritized list of stealth companies ready to hand off to your business development team.
"One of our biggest challenges in the past was relying on data sets that were not current, incomplete and irrelevant.
The more effective you can target a client in terms of your business outreach, the more effective your sales and business development process is going to be.
Zymewire is proving itself to be one of the most important tools in our toolkit."
AXONIS Therapeutics is a Boston-based biotech dedicated to advancing breakthrough therapies in the field of neurotherapeutics. Backed by a ...
Review of 2023 Biopharma Funding: How can sales and business development teams at service providers adapt for 2024?
We are obsessed with finding new ways to help your biopharma sales professionals generate more qualified leads.
Our human-verified AI scans thousands of documents every day, separates the signal from the noise, and delivers value in the form of actionable sales intelligence.